APA (7th ed.) Citation

Advani, S., Biswas, G., Sinha, S., Rayala, N. N., Chary, S., Thakur, P., . . . Bandi, V. K. A randomized, multiple-dose, multicenter, comparative parallel study to evaluate the safety and efficacy of intravenous infusion of rituximab (Hetero) and reference medicinal product (Rituximab, Roche) in Indian patients of non-hodgkin's lymphoma (HERILY). Thieme Medical and Scientific Publishers Pvt. Ltd.

Chicago Style (17th ed.) Citation

Advani, Suresh, Ghanashyam Biswas, Shubhadeep Sinha, Neetu Naidu Rayala, Sreenivasa Chary, Pankaj Thakur, Anushrita, Santanu Tripathi, and Vamsi Krishna Bandi. A Randomized, Multiple-dose, Multicenter, Comparative Parallel Study to Evaluate the Safety and Efficacy of Intravenous Infusion of Rituximab (Hetero) and Reference Medicinal Product (Rituximab, Roche) in Indian Patients of Non-hodgkin's Lymphoma (HERILY). Thieme Medical and Scientific Publishers Pvt. Ltd.

MLA (9th ed.) Citation

Advani, Suresh, et al. A Randomized, Multiple-dose, Multicenter, Comparative Parallel Study to Evaluate the Safety and Efficacy of Intravenous Infusion of Rituximab (Hetero) and Reference Medicinal Product (Rituximab, Roche) in Indian Patients of Non-hodgkin's Lymphoma (HERILY). Thieme Medical and Scientific Publishers Pvt. Ltd.